Showing 49–60 of 112 results

Lonsurf 15 mg Alternative – Loncil (Trifluridine / Tipiracil) 15 mg Tablet | Beacon Pharmaceuticals

Loncil 15 mg (Trifluridine / Tipiracil) Tablet by Beacon Pharmaceuticals. Reference brand: Lonsurf. oral antineoplastic combination; used in selected previously treated metastatic colorectal cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Lonsurf 20 mg Alternative – Loncil (Trifluridine / Tipiracil) 20 mg Tablet | Beacon Pharmaceuticals

Loncil 20 mg (Trifluridine / Tipiracil) Tablet by Beacon Pharmaceuticals. Reference brand: Lonsurf. oral antineoplastic combination; used in selected previously treated metastatic colorectal cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Lorbrena / Lorviqua 100 mg Alternative – Lorbrexen (Lorlatinib) 100 mg Tablet | Everest Pharmaceuticals

Lorbrexen 100 mg (Lorlatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lorbrena / Lorviqua (Pfizer). It belongs to the ALK inhibitor class and is used in selected ALK-positive metastatic non-small cell lung cancer.

Active ingredient: Lorlatinib
Strength: 100 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Lumakras / Lumykras 120 mg Alternative – Sotoxen (Sotorasib) 120 mg Tablet | Everest Pharmaceuticals

Sotoxen 120 mg (Sotorasib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lumakras / Lumykras (Amgen). It belongs to the KRAS G12C inhibitor class and is used in selected KRAS G12C-mutated non-small cell lung cancer.

Active ingredient: Sotorasib
Strength: 120 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Lynparza 100 mg Alternative – Olapar (Olaparib) 100 mg Tablet | Beacon Pharmaceuticals

Olapar 100 mg (Olaparib) Tablet by Beacon Pharmaceuticals. Reference brand: Lynparza. PARP inhibitor; used in selected ovarian, breast, pancreatic and prostate cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Lynparza 150 mg Alternative – Olanib (Olaparib) 150 mg Tablet | Everest Pharmaceuticals

Olanib 150 mg (Olaparib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Lynparza (AstraZeneca / MSD). It belongs to the PARP inhibitor class and is used in selected ovarian, breast, pancreatic and prostate cancers.

Active ingredient: Olaparib
Strength: 150 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Lynparza 150 mg Alternative – Olapar (Olaparib) 150 mg Tablet | Beacon Pharmaceuticals

Olapar 150 mg (Olaparib) Tablet by Beacon Pharmaceuticals. Reference brand: Lynparza. PARP inhibitor; used in selected ovarian, breast, pancreatic and prostate cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Megace 160 mg Alternative – Mezoxia (Megestrol acetate) 160 mg Tablet | Everest Pharmaceuticals

Mezoxia 160 mg (Megestrol acetate) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Megace (Bristol Myers Squibb). It belongs to the progestin class and is used in certain hormone-responsive cancer settings depending on formulation and jurisdiction.

Active ingredient: Megestrol acetate
Strength: 160 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Nexavar 200 mg Alternative – Hepanib (Sorafenib) 200 mg Tablet | Everest Pharmaceuticals

Hepanib 200 mg (Sorafenib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Nexavar (Bayer). It belongs to the multikinase inhibitor class and is used in selected liver, kidney and thyroid cancers.

Active ingredient: Sorafenib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Nexavar 200 mg Alternative – Soranix (Sorafenib) 200 mg Tablet | Beacon Pharmaceuticals

Soranix 200 mg (Sorafenib) Tablet by Beacon Pharmaceuticals. Reference brand: Nexavar. multikinase inhibitor; used in selected liver, kidney and thyroid cancers. Prescription medicine. Brand comparison does not establish interchangeability.

Nolvadex 20 mg Alternative – Tamoxi (Tamoxifen) 20 mg Tablet | Beacon Pharmaceuticals

Tamoxi 20 mg (Tamoxifen) Tablet by Beacon Pharmaceuticals. Reference brand: Nolvadex. selective estrogen receptor modulator; used in selected hormone receptor-positive breast cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Ofev 100 mg Alternative – Ninacent (Nintedanib) 100 mg Capsule | Incepta Pharmaceuticals

Ninacent 100 mg (Nintedanib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Ofev (Boehringer Ingelheim).

Pack: 10 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.